Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial
ConclusionHigh implementation adherence and persistence with apixaban were observed in patients with NVAF receiving apixaban. The educational program did not show additional benefits.Clinical trial registrationThis study is registered at ClinicalTrials.gov [NCT01884350].
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular | Clinical Trials | Diabetes | Education | Endocrinology | Heart | Heart Failure | Hypertension | Ischemic Stroke | Stroke | Study | Vitamin K | Vitamins